Baxter International Inc. (BAX): Price and Financial Metrics


Baxter International Inc. (BAX): $51.30

-1.92 (-3.61%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

BAX POWR Grades

  • Growth is the dimension where BAX ranks best; there it ranks ahead of 81.54% of US stocks.
  • BAX's strongest trending metric is Quality; it's been moving down over the last 177 days.
  • BAX ranks lowest in Quality; there it ranks in the 16th percentile.

BAX Stock Summary

  • BAXTER INTERNATIONAL INC's market capitalization of $25,861,394,937 is ahead of 91.63% of US-listed equities.
  • BAXTER INTERNATIONAL INC's stock had its IPO on January 1, 1986, making it an older stock than 93.49% of US equities in our set.
  • In terms of twelve month growth in earnings before interest and taxes, BAXTER INTERNATIONAL INC is reporting a growth rate of -226.06%; that's higher than only 6.78% of US stocks.
  • If you're looking for stocks that are quantitatively similar to BAXTER INTERNATIONAL INC, a group of peers worth examining would be LYB, HAS, XRAY, TEVA, and XRX.
  • Visit BAX's SEC page to see the company's official filings. To visit the company's web site, go to www.baxter.com.

BAX Valuation Summary

  • In comparison to the median Healthcare stock, BAX's price/sales ratio is 63.27% lower, now standing at 1.8.
  • Over the past 243 months, BAX's price/earnings ratio has gone down 38.5.

Below are key valuation metrics over time for BAX.

Stock Date P/S P/B P/E EV/EBIT
BAX 2022-12-01 1.8 4.8 -11.1 -21.3
BAX 2022-11-30 1.9 5.1 -12.0 -22.4
BAX 2022-11-29 1.9 5.0 -11.7 -22.1
BAX 2022-11-28 1.9 5.0 -11.7 -22.1
BAX 2022-11-25 1.9 5.1 -11.9 -22.3
BAX 2022-11-23 1.9 5.1 -11.9 -22.3

BAX Growth Metrics

    The 5 year net income to common stockholders growth rate now stands at -79.44%.
  • Its 5 year net cashflow from operations growth rate is now at 35.07%.
  • The 2 year revenue growth rate now stands at 17.46%.
Over the past 52 months, BAX's revenue has gone up $3.74e+09.

The table below shows BAX's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 14,740 1,465 -2,376
2022-06-30 14,193 1,850 1,011
2022-03-31 13,545 2,053 1,057
2021-12-31 12,784 2,222 1,284
2021-09-30 12,451 2,241 1,214
2021-06-30 12,197 2,076 1,120

BAX's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • BAX has a Quality Grade of C, ranking ahead of 64.68% of graded US stocks.
  • BAX's asset turnover comes in at 0.631 -- ranking 63rd of 186 Medical Equipment stocks.
  • PEN, MDT, and IART are the stocks whose asset turnover ratios are most correlated with BAX.

The table below shows BAX's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-09-30 0.631 0.393 0.106
2021-06-30 0.616 0.391 0.102
2021-03-31 0.598 0.387 0.096
2020-12-31 0.594 0.393 0.098
2020-09-30 0.600 0.407 0.069
2020-06-30 0.617 0.414 0.072

BAX Price Target

For more insight on analysts targets of BAX, see our BAX price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $94.21 Average Broker Recommendation 1.56 (Moderate Buy)

BAX Stock Price Chart Interactive Chart >

Price chart for BAX

BAX Price/Volume Stats

Current price $51.30 52-week high $89.70
Prev. close $53.22 52-week low $49.83
Day low $51.13 Volume 5,018,200
Day high $52.98 Avg. volume 3,420,969
50-day MA $54.73 Dividend yield 2.26%
200-day MA $65.81 Market Cap 25.86B

Baxter International Inc. (BAX) Company Bio


Baxter International Inc. is an American multinational health care company with headquarters in Deerfield, Illinois. (Source:Wikipedia)


BAX Latest News Stream


Event/Time News Detail
Loading, please wait...

BAX Latest Social Stream


Loading social stream, please wait...

View Full BAX Social Stream

Latest BAX News From Around the Web

Below are the latest news stories about BAXTER INTERNATIONAL INC that investors may wish to consider to help them evaluate BAX as an investment opportunity.

Baxter Introduces ExactaMix Pro, Next-Generation Automated Nutrition Compounder, at ASHP Meeting

DEERFIELD, Ill., December 01, 2022--Baxter International Inc. (NYSE:BAX), a global leader in nutrition therapy, announces the launch of the ExactaMix Pro Automated Compounder, which is expected to be available to customers in the United States in early 2023. ExactaMix Pro will be on display at Baxter’s booth #937 at the American Society of Health-System Pharmacists (ASHP) 2022 Midyear Clinical Meeting taking place Dec. 4 – Dec. 8, 2022, in Las Vegas.

Yahoo | December 1, 2022

FDA classifies Baxter’s hospital bed system recall as most serious

The U.S. health regulator on Wednesday classified the recall of hospital bed systems by Baxter International Inc, as the most serious type, on concerns it could lead to life-threatening injuries or death. Baxter initiated the recall of its WatchCare Incontinence Management System, which is used to discreetly alert an incontinent patient’s caregiver of involuntary urination […]

National Post | November 23, 2022

Baxter recalls WatchCare devices over interference risk (NYSE:BAX)

The U.S. Food and Drug Administration ((FDA)) announced Wednesday that Baxter International (BAX) had recalled more than 8,500 WatchCare Incontinence Management Systems after finding…

Seeking Alpha | November 23, 2022

CORRECTED-FDA classifies Baxter's hospital bed system recall as most serious

The U.S. health regulator on Wednesday classified the recall of hospital bed systems by Baxter International Inc, as the most serious type, on concerns it could lead to life-threatening injuries or death. Baxter initiated the recall of its WatchCare Incontinence Management System, which is used to discreetly alert an incontinent patient's caregiver of involuntary urination or defecation, by sending a correction letter to its customers in late September. In the letter, Baxter warned users about the potential for WatchCare's radio frequencies to interfere with other medical devices.

Yahoo | November 23, 2022

Do you want to know where to find good stock? Take a look at Baxter International Inc.’s (NYSE:BAX) Sentiment Analysis

Currently, Baxter International Inc.’s (BAX) stock is trading at $54.89, marking a gain of 1.05% from last night’s close. At this price, the stock is -38.81% below its 52-week high of $89.70 and 10.15% above its 52-week low of $49.83. Based on the past 30-day period, the stock price is -5.42% below the high and […]

US Post News | November 18, 2022

Read More 'BAX' Stories Here

BAX Price Returns

1-mo 1.95%
3-mo -12.20%
6-mo -28.05%
1-year -34.13%
3-year -35.64%
5-year -13.94%
YTD -39.19%
2021 8.48%
2020 -2.95%
2019 28.40%
2018 2.89%
2017 47.30%

BAX Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full BAX Dividend History

Continue Researching BAX

Want to see what other sources are saying about Baxter International Inc's financials and stock price? Try the links below:

Baxter International Inc (BAX) Stock Price | Nasdaq
Baxter International Inc (BAX) Stock Quote, History and News - Yahoo Finance
Baxter International Inc (BAX) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.7394 seconds.